SCHEMBL8919476

SCHEMBL8919476

COC(=O)C1C(C(=O)OC)C1C(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.50
PPM1B O75688 1/20 0.46
PTPN1 P18031 1/20 0.46
PPP1CC P36873 1/20 0.46
ALDH1A1 P00352 1/20 0.44
POLB P06746 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.39
CHRNB2 P17787 2/20 0.39
CHRNA4 P43681 2/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA7 P36544 1/20 0.39
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
HCAR2 Q8TDS4 1/20 0.37
TSHR P16473 1/20 0.37
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
BRD4 O60885 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20075282 1.00 CYP2C19 (0.50) CYP2C19PPM1BPTPN1PPP1CCALDH1A1
SCHEMBL2080386 1.00 CYP2C19 (0.50) CYP2C19PPM1BPTPN1PPP1CCALDH1A1
SCHEMBL13139972 1.00 CYP2C19 (0.50) CYP2C19PPM1BPTPN1PPP1CCALDH1A1
SCHEMBL2081942 1.00 CYP2C19 (0.50) CYP2C19PPM1BPTPN1PPP1CCALDH1A1
SCHEMBL5490936 0.87 PPM1B (0.56) CYP2C19PPM1BPTPN1PPP1CCALDH1A1
SCHEMBL257600 0.87 PPM1B (0.56) CYP2C19PPM1BPTPN1PPP1CCALDH1A1
SCHEMBL8917467 0.87 PPM1B (0.56) CYP2C19PPM1BPTPN1PPP1CCALDH1A1
SCHEMBL4036804 0.87 PPM1B (0.56) CYP2C19PPM1BPTPN1PPP1CCALDH1A1
SCHEMBL11788035 0.86 CYP2C19 (0.46) CYP2C19PPM1BPTPN1PPP1CCALDH1A1
SCHEMBL2132206 0.85 CYP2C19 (0.41) CYP2C19PPM1BPTPN1PPP1CCPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0805682-A1 DERMATOLOGICAL USE OF VITAMIN D DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1997-11-12 EP disclosed
US-5623078-A Process for producing an intermediate of a new quinolone compound CHISSO CORPORATION (JP) 1997-04-22 US disclosed
WO-1996022776-A1 DERMATOLOGICAL USE OF VITAMIN D DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1996-08-01 WO disclosed